Skip to main content

ORIGINAL RESEARCH article

Front. Public Health
Sec. Infectious Diseases: Epidemiology and Prevention
Volume 12 - 2024 | doi: 10.3389/fpubh.2024.1476748

Trends and projections of Hepatitis A Incidence in eastern China from 2007 to 2021: An Age-Period-Cohort Analysis

Provisionally accepted
Peng Hui Peng Hui 1Wang Yin Wang Yin 2Wei Songting Wei Songting 3Kang Weili Kang Weili 2Xiaoqing Cheng Xiaoqing Cheng 4*Chang-jun Bao Chang-jun Bao 4*Zhang Xuefeng Zhang Xuefeng 4
  • 1 GuSu Center for Disease Prevention and Control, Suzhou, China
  • 2 Yangzhou Center for Disease Control and Prevention, Yangzhou, Jiangsu Province, China
  • 3 Heilongjiang Provincial Animal Disease Prevention and Control Center, Harbin, Heilongjiang Province, China
  • 4 Jiangsu Provincial Center for Disease Control And Prevention, Nanjing, Jiangsu Province, China

The final, formatted version of the article will be published soon.

    Objective: This study analyzes the trends in Hepatitis A incidence associated with age, period, and birth cohorts from 2007 to 2021 in Jiangsu Province, China, and projects the future burden through 2031.Methods: Data on Hepatitis A cases in Jiangsu Province from 2007 to 2021 were obtained from the National Notifiable Disease Reporting System. Joinpoint regression analysis identified significant changes in incidence trends. The age-period-cohort model assessed the effects of age, period, and cohort on Hepatitis A incidence rates. Projections for 2022-2031 were generated using the Bayesian age-period-cohort model.From 2007 to 2021, Hepatitis A incidence in Jiangsu Province significantly declined, with an average annual percent change (AAPC) of -10.77%. The decline was more pronounced in males (AAPC = -12.87%) compared to females (AAPC = -7.46%). The overall net drift was -10.61% (95% CI: -11.14% to -10.07%), the net drift for males was -12.77% (95% CI: -13.40% to -12.13%), which was higher than that for females at -7.27% (95% CI: -7.93% to -6.60%).The local drift indicates the incidence of hepatitis A decreased gradually, with the rate of decline slowing in the later period. Descriptive analysis revealed the highest incidence of Hepatitis A cases in the 40-59 age group, while age-period-cohort analysis indicated higher incidence rates in younger individuals. The cohort effect showed a continuous decline from the earliest cohort in 1923-1927 (Overall RR = 64.93, 95% CI: 42.55 to 99.07) to the most recent cohort in 1993-1997 (Overall RR = 0.008, 95% CI: 0.004 to 0.01).But Bayesian age-period-cohort model projections for 2022-2031 suggest that incidence rates will remain low, though they may slightly increase by 2031, with peak incidence shifting to the 60-64 age group.The incidence of Hepatitis A in Jiangsu Province has significantly decreased from 2007 to 2021, primarily due to public health measures and vaccination programs. Future efforts should focus on maintaining vaccination coverage and improving sanitation and hygiene practices to sustain these achievements.

    Keywords: Hepatitis A, age-period-cohort model, incidence trends, Public Health, Jiangsu Province, BAPC model

    Received: 06 Aug 2024; Accepted: 21 Nov 2024.

    Copyright: © 2024 Hui, Yin, Songting, Weili, Cheng, Bao and Xuefeng. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Xiaoqing Cheng, Jiangsu Provincial Center for Disease Control And Prevention, Nanjing, 210028, Jiangsu Province, China
    Chang-jun Bao, Jiangsu Provincial Center for Disease Control And Prevention, Nanjing, 210028, Jiangsu Province, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.